Hankook Cosmetics Co., Ltd.

KSE 123690.KS

Hankook Cosmetics Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 19.63 M

Hankook Cosmetics Co., Ltd. Shareholders' Equity is USD 19.63 M for the year ending December 31, 2023, a 9.77% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Hankook Cosmetics Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 17.88 M, a -2.90% change year over year.
  • Hankook Cosmetics Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 18.41 M, a -31.97% change year over year.
  • Hankook Cosmetics Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 27.07 M, a -10.78% change year over year.
  • Hankook Cosmetics Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 30.34 M, a -35.70% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
KSE: 123690.KS

Hankook Cosmetics Co., Ltd.

CEO Mr. Yong Joon Lee
IPO Date June 1, 2010
Location South Korea
Headquarters 35, Cheonggyecheon-ro
Employees 48
Sector Consumer Discretionary
Industries
Description

Hankook Cosmetics Co., Ltd. produces and sells cosmetics in South Korea and internationally. It offers its products under the Sansim, Hyoum, Ossion, Jutanhak, Secret Nature, Calli, GENERTE, A3F[on], Temptation, CONTINUE, Chess The Classic, CLASSYGIRL, Beautri, BEAUTENIQUE, Dr Medix, and Parapam brands. The company was founded in 1961 and is based in Seoul, South Korea.

Similar companies

003350.KS

Hankook Cosmetics Manufacturing Co., Ltd

USD 29.62

-5.88%

128820.KS

Daesung Industrial Co., Ltd.

USD 2.14

-1.25%

128940.KS

Hanmi Pharm. Co., Ltd.

USD 159.35

-4.24%

000240.KS

Hankook & Company Co., Ltd.

USD 11.36

-2.60%

012510.KS

Douzone Bizon Co., Ltd.

USD 45.70

-2.47%

StockViz Staff

February 4, 2025

Any question? Send us an email